Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)
The hypothesis presents a coherent mechanism linking neuroinflammation to oligodendrocyte death through ALOX15-mediated ferroptosis. The mechanistic chain proceeds as follows:
1. Substrate vulnerability: Oligodendrocytes require exceptionally high PUFA content for myelin membrane synthesis, particularly AA-PE and AdA-PE at the sn-2 position of PE
2. Enzymatic catalysis: ALOX15 stereospecifically oxygenates these substrates to 15-HpETE-PE and related hydroperoxides
3. Calcium amplification: NMDA receptor activation elevates intracellular Ca²⁺, promoting calmodulin binding to ALOX15 and enhancing catalytic activity
4. Death execution: PUFA-PE hydroperoxides bypass the need for iron-catalyzed initiation and directly propagate lipid peroxidation cascades
The proposal that this represents a distinct pathway from microglial ferroptosis is mechanistically sound. ALOX15-independent ferroptosis in microglia typically involves iron-dependent Fenton chemistry acting on free or loosely-bound PUFAs, whereas the enzymatic route specifically targets esterified PUFA pools. This compartmentalization has therapeutic implications, as ALOX15 inhibitors would selectively protect oligodendrocytes.
|
This hypothesis presents a mechanistically plausible pathway connecting ALOX15 enzymatic activity to oligodendrocyte death via ferroptosis in Alzheimer's Disease. The target has favorable druggability characteristics and a history of drug discovery efforts, though significant translational challenges exist, particularly regarding human relevance in AD and safety liabilities from eicosanoid pathway modulation.
Confidence Score: 0.62 (revised downward from 0.82 given translational context)
---
Verdict: ALOX15 is a druggable target with established medicinal chemistry precedent. The active site iron creates both opportunities (high-affinity chelation-based inhibitors) and challenges (specificity across lipoxygenase family).
---
| Compound | Specificity | Limitation |
|----------|-------------|------------|
| PD146176 (BL-0007) | Selective for ALOX15 | Developed for EAE/MS; limited
---
| Dimension | Score (0-1) | Rationale |
|-----------|-------------|-----------|
| Mechanistic Plausibility | 0.78 | Well-characterized enzymology; substrate vulnerability in myelin-producing cells is biologically coherent; calcium regulation provides logical amplification |
| Evidence Strength | 0.54 | Strong preclinical evidence in EAE/stroke; critical absence of direct AD oligodendrocyte data; human AD tissue studies lacking specificity |
| Novelty | 0.71 | Represents a distinct ferroptosis subtype (enzymatic vs. iron-catalyzed) with unique cellular specificity; underexplored in AD context |
| Feasibility | 0.62 | Target is druggable (enzymatic class), but blood-brain barrier penetration for